Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder

Psychiatric Genetics

Volumn 23, Issue 1, 2013, Pages 20-28

  Jackson, Kia J ^a   Fanous, Ayman H ^a,b,c   Chen, Jingchun ^a   Kendler, Kenneth S ^a   Chen, Xiangning ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

15q25 gene cluster; bipolar disorder; CHRNA5; nicotine dependence; schizophrenia

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CHROMOSOME 15Q; EUROPEAN AMERICAN; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BIPOLAR DISORDER; BRAIN; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIGENE FAMILY; NERVE TISSUE PROTEINS; RECEPTORS, NICOTINIC; RISK FACTORS; SCHIZOPHRENIA;

NICOTIANA TABACUM;

EID: 84871796589     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32835bd5f1     Document Type: Article

References (56)

1. Bierut LJ (2010). Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci 31:46-51.
2. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, et al. (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171.
3. Bramon E, Sham PC (2001). The common genetic liability between schizophrenia and bipolar disorder: a review. Curr Psychiatry Rep 3:332-337.
4. Buckley PF (1998). Substance abuse in schizophrenia: a review. J Clin Psychiatry 59:26-30.
5. Cerullo MA, Strakowski SM (2007). The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2:29.
6. Chen LS, Xian H, Grucza RA, Saccone NL,Wang JC, Johnson EO, et al. (2012). Nicotine dependence and comorbid psychiatric disorders: examination of specific genetic variants in the CHRNA5-A3-B4 nicotinic receptor genes. Drug Alcohol Depend 123:S42-S51, http://dx.doi.org.proxy.library.vcu.edu/ 10.1016/j.drugalcdep.2012.01.014.
7. Dalack GW, Healy DJ, Meador-Woodruff JH (1998). Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings. Am J Psychiatry 155:1490-1501.
8. De Leon J, Diaz FJ (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76:135-157.
9. DeQuardo JR, Carpenter CF, Tandon R (1994). Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res 28:267-275.
10. Diaz FJ, James D, Botts S, Maw L, Susce MT, de Leon J (2009). Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord 11:154-165.
11. Dudbridge F (2008). Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98.
12. Erlich PM, Hoffman SN, Rukstalis M, Han JJ, Chu X, Linda Kao WH, et al. (2010). Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity. Hum Genet 128:491-499.
13. Fanous AH, van den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, et al. (2005). Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162:1824-1832.
14. Gejman PV, Sanders AR, Badner JA, Cao Q, Zhang J (2001). Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet 105:789-793.
15. Goff DC, Henderson DC, Amico E (1992). Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 149:1189-1194.
16. Griffith JM, O'Neill JE, Petty F, Garver D, Young D, Freedman R (1998). Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biol Psychiatry 44:98-106.
17. Grucza RA, Wang JC, Stitzel JA, Hinrichs AL, Saccone SF, Saccone NL, et al. (2008). A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol Psychiatry 64:922-929.
18. Hall RG, Duhamel M, McClanahan R, Miles G, Nason C, Rosen S, et al. (1995). Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J Nerv Ment Dis 183:468-471.
19. Hong LE, Yang X,Wonodi I, Hodgkinson CA, Goldman D, Stine OC, et al. (2011). A CHRNA5 allele related to nicotine addiction and schizophrenia. Gene Brain Behav 10:530-535.
20. Kalman D, Morrissette SB, George TP (2005). Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14:106-123.
21. Kendler KS, O'Neill FA, Burke J, Murphy B, Duke F, Straub RE, et al. (1996). Irish study on high-density schizophrenia families: field methods and power to detect linkage. Am J Med Genet 67:179-190.
22. Kendler KS, Prescott CA, Myers J, Neale MC (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 60:929-937.
23. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH (2000). Smoking and mental illness: a population-based prevalence study. JAMA 284:2606-2610.
24. Leonard S, Mexal S, Freedman R (2007). Smoking, genetics, and schizophrenia: evidence for self medication. J Dual Diagn 3:43-59.
25. Lewis CM, Levinson DF,Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48.
26. Li MD (2006). The genetics of nicotine dependence. Curr Psychiatry Rep 8:158-164.
27. Li MD, Xu Q, Lou XY, Payne TJ, Niu T, Ma JZ (2010). Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans. Am J Med Genet B Neuropsychiatr Genet 153B:745-756.
28. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. (2009). Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234-239.
29. Lips EH, Gaborieau V, McKay JD, Chabrier A, Hung RJ, Boffetta P, et al. (2010). Association between a 15q25 gene variant, smoking quantity and tobaccorelated cancers among 17000 individuals. Int J Epidemiol 39:563-577.
30. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, et al. (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42:436-440.
31. Lyons MJ, Bar JL, Kremen WS, Toomey R, Eisen SA, Goldberg J (2002). Nicotine and familial vulnerability to schizophrenia: a discordant twin study. J Abnorm Psychol 111:687-693.
32. Magi R, Morris AP (2010). GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11:288.
33. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, et al. (1990). Prevalence of substance abuse in schizophrenia: demographics and clinical correlates. Schizophr Bull 16:31-54.
34. Nyholt DR (2004). A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
35. Patkar AA, Gopalakrishnan R, Lundy A, Leone FT, Certa KM, Weinstein SP (2002). Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis 190:604-610.
36. Petrovsky N, Quednow BB, Ettinger U, Schmechtig A, Mo? ssner R, Collier DA, et al. (2010). Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology 35:1429-1439.
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. (2007). PLINK: a toolset for whole-genome association and populationbased linkage analysis. Am J Hum Genet 81:559-575.
38. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, Wormley B, et al. (2009). The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115:245-253.
39. Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, et al. (2009). Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 150B:453-466.
40. Scheet P, Stephens M (2006). A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78:629-644.
41. Shao L, Vawter MP (2008). Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 64:89-97.
42. Sherva R, Kranzler HR, Yu Y, Logue MW, Poling J, Arias AJ, et al. (2010). Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 35:1921- 1931.
43. Strakowski SM, Tohen M, Flaum M, Amador X (1994). Substance abuse in psychotic disorders: associations with affective syndromes. Schizophr Res 14:73-81.
44. Sullivan PF, Kendler KS, Neale MC (2003). Schizophrenia as a complex trait: evidence from a meta analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
45. Sullivan PF, Lin D, Tzeng JY, van den OE, Perkins D, Stroup TS, et al. (2008). Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13:570-584.
46. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM (2005). Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend 80:259-265.
47. Tobacco and Genetics (TAG) Consortium (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42:441-447.
48. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. (1998). Cooccurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55:967-972.
49. Vanable PA, Carey MP, Carey KB, Maisto SA (2003). Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 17:259-265.
50. Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP, et al. (2009). Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 18:3125-3135.
51. Ware JJ, van den Bree MB, Munafo MR (2011). Association of the CHRNA5-A3- B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res 13:1167-1175.
52. Webster JA, Gibbs JR, Clarke J, Ray M, Zhang W, Holmans P, et al. (2009). Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet 84:445-458.
53. Winterer G (2010). Why do patients with schizophrenia smoke? Curr Opin Psychiatry 23:112-119.
54. Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, Brenner H, et al. (2010). Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3- CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet 153B:1448-1458.
55. World Health Organization (2008). WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization Press.
56. Zhang H, Kranzler HR, Poling J, Gelernter J (2010). Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility. Neuropsychopharmacology 35:2211-2224.